<html>
<head>PUBMED IDs for PPAPDC1</head>
<body bgcolor='#C5F0F2'><h1>PPAPDC1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18757432/'>Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.</a> September 2  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21748818/'>High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.</a> December 23  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24051013/'>PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.</a> June 11  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25201346/'>Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers.</a> June 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27819739/'>Identification of significantly different modules between permanent and deciduous teeth by network and pathway analyses.</a> March 1  2016<br></body></html>
